EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

High-dose dexmedetomidine versus dexamethasone supplementation to interscalene brachial plexus block in arthroscopic shoulder surgery: A randomized, controlled trial

Thirada Srinil, Busara Sirivanasandha, Pathom Halilamien, Pawinee Pangthipampai, Jerattikul Phumchaitheerachort, Patcharaon Sangjak, Suppachai Poolsuppasit iD

PLOS One · 07.08.2026 · 21 (8) · e0353121

DOI: 10.1371/journal.pone.0353121 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 07.08.2026. Verfasst von Thirada Srinil und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Dexmedetomidine, Dexamethasone, Brachial Plexus Block, Arthroscopy. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine Siriraj Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this double-blind, randomized controlled trial, we compared the efficacy of perineural 2 µg/kg dexmedetomidine and 5 mg dexamethasone as adjuvants to bupivacaine for postoperative pain control in patients undergoing arthroscopic shoulder surgery. We hypothesized that the combination of bupivacaine with dexmedetomidine would prolong analgesia compared with dexamethasone.

Methods

One hundred twelve patients scheduled for arthroscopic shoulder surgery were randomized to receive 15 mL of 0.33% bupivacaine with either 2 µg/kg of dexmedetomidine or 5 mg of dexamethasone during ultrasound-guided interscalene brachial plexus block (ISB). The primary outcome was the duration of analgesia (DOA), analyzed as a time-to-event variable using Kaplan–Meier survival curves with log-rank testing. Secondary outcomes included the duration of sensory block (DOS) and motor block (DOM), pain scores, incidence and severity of rebound pain, opioid consumption, patient satisfaction, and adverse effects. Longitudinal pain scores were evaluated using a regression model.

Results

Of 112 randomized patients, 107 were included in the primary analysis. Dexmedetomidine and dexamethasone produced a similar DOA (median, 16.77 vs 12.48 h; median difference in location 5.24 h, 95% CI −0.47 to 9.17; p = 0.655). The dexmedetomidine group had a significantly longer DOS (19.8 vs. 17.3 h; mean difference 2.45 h, 95% CI 0.23 to 4.65; p = 0.031) and DOM (19.9 vs. 17.8 h; median difference in location 2.23 h, 95% CI 1.02 to 3.60; p = 0.008). Postoperative pain score at 6, 12, 18, and 24 hours were comparable, as were rebound pain, postoperative nausea and vomiting (PONV), patient satisfaction, and opioid consumption. The dexmedetomidine group had a higher incidence of intraoperative hypotension (risk difference [RD] 44.4%, 95% CI 30.0% to 59.9%; p < 0.001), bradycardia in the block room (RD 17.9%; p = 0.010) and intraoperatively (RD 27.6%; p = 0.004), and postoperative sedation (RD 10.9%; p = 0.027); however, all hemodynamic events were transient and did not require intensive care admission.

Conclusions

Perineural dexmedetomidine (2 µg/kg) was not shown to be superior to dexamethasone (5 mg) in prolonging analgesia when added to bupivacaine for ISB in arthroscopic shoulder surgery. Although dexmedetomidine prolonged sensory and motor block duration, this did not translate into a longer DOA and was associated with higher rates of hemodynamic instability and sedation. These findings suggest limited clinical benefit and raise safety concerns regarding higher dexmedetomidine doses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineDexamethasoneBrachial Plexus BlockArthroscopyPostoperative PainShoulderHumansFemaleMaleDouble-Blind MethodMiddle AgedAdultBupivacaine

Substanzen

DexmedetomidineDexamethasoneBupivacaine

Autor:innen und Institutionen

  • Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Suppachai Poolsuppasit

Förderung

  • Faculty of Medicine Siriraj Hospital

Zitieren

APA

Srinil, T., Sirivanasandha, B., Halilamien, P., Pangthipampai, P., Phumchaitheerachort, J., Sangjak, P., & Poolsuppasit, S. (2026). High-dose dexmedetomidine versus dexamethasone supplementation to interscalene brachial plexus block in arthroscopic shoulder surgery: A randomized, controlled trial. PLOS One, 21(8), e0353121. https://doi.org/10.1371/journal.pone.0353121

Vancouver

Srinil T, Sirivanasandha B, Halilamien P, Pangthipampai P, Phumchaitheerachort J, Sangjak P, et al. High-dose dexmedetomidine versus dexamethasone supplementation to interscalene brachial plexus block in arthroscopic shoulder surgery: A randomized, controlled trial. PLOS One. 2026;21(8):e0353121. doi:10.1371/journal.pone.0353121

BibTeX
@article{Srinil2026,
  author = {Srinil, Thirada and Sirivanasandha, Busara and Halilamien, Pathom and Pangthipampai, Pawinee and Phumchaitheerachort, Jerattikul and Sangjak, Patcharaon and Poolsuppasit, Suppachai},
  title = {High-dose dexmedetomidine versus dexamethasone supplementation to interscalene brachial plexus block in arthroscopic shoulder surgery: A randomized, controlled trial},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0353121},
  doi = {10.1371/journal.pone.0353121}
}
Kostenlos starten →